[HTML][HTML] PPARγ as a therapeutic target to rescue mitochondrial function in neurological disease
There is increasing evidence for the involvement of mitochondrial dysfunction and oxidative
stress in the pathogenesis of many of the major neurodegenerative and neuroinflammatory …
stress in the pathogenesis of many of the major neurodegenerative and neuroinflammatory …
Neurochemical regulation of the expression and function of glial fibrillary acidic protein in astrocytes
D Li, X Liu, T Liu, H Liu, L Tong, S Jia, YF Wang - Glia, 2020 - Wiley Online Library
Glial fibrillary acidic protein (GFAP), a type III intermediate filament, is a marker of mature
astrocytes. The expression of GFAP gene is regulated by many transcription factors (TFs) …
astrocytes. The expression of GFAP gene is regulated by many transcription factors (TFs) …
Chronic neuropathic pain: it's about the rhythm
Z Alshelh, F Di Pietro, AM Youssef… - Journal of …, 2016 - Soc Neuroscience
The neural mechanisms underlying the development and maintenance of chronic
neuropathic pain remain unclear. Evidence from human investigations suggests that …
neuropathic pain remain unclear. Evidence from human investigations suggests that …
[HTML][HTML] Pharmacological treatment of chemotherapy-induced neuropathic pain: PPARγ agonists as a promising tool
NLM Quintão, JR Santin, LC Stoeberl… - Frontiers in …, 2019 - frontiersin.org
Chemotherapy-induced neuropathic pain (CINP) is one of the most severe side effects of
anticancer agents, such as platinum-and taxanes-derived drugs (oxaliplatin, cisplatin …
anticancer agents, such as platinum-and taxanes-derived drugs (oxaliplatin, cisplatin …
Role of JAK-STAT and PPAR-gamma signalling modulators in the prevention of autism and neurological dysfunctions
The Janus-kinase (JAK) and signal transducer activator of transcription (STAT) signalling
pathways regulate gene expression and control various factors involved in normal …
pathways regulate gene expression and control various factors involved in normal …
A network pharmacology approach to predict potential targets and mechanisms of “Ramulus Cinnamomi (cassiae) – Paeonia lactiflora” herb pair in the treatment of …
HT Pan, ZQ Xi, XQ Wei, K Wang - Annals of Medicine, 2022 - Taylor & Francis
Abstract Background Traditional Chinese medicine (TCM) prescriptions have multiple
bioactive properties.“Gui Zhi–Shao Yao” herb pair is widely used to treat chronic pain (CP) …
bioactive properties.“Gui Zhi–Shao Yao” herb pair is widely used to treat chronic pain (CP) …
Acute and chronic pain processing in the thalamocortical system of humans and animal models
The transmission of noxious stimuli from peripheral receptors to the cortex involves multiple
central ascending pathways. While projections to areas in the brainstem and diencephalon …
central ascending pathways. While projections to areas in the brainstem and diencephalon …
[HTML][HTML] PPARγ activation mitigates mechanical allodynia in paclitaxel-induced neuropathic pain via induction of Nrf2/HO-1 signaling pathway
YQ Zhou, DQ Liu, SP Chen, N Chen, J Sun… - Biomedicine & …, 2020 - Elsevier
Paclitaxel-induced neuropathic pain (PINP) is a dose-limiting side effect and is refractory to
widely used analgesic drugs. Previous studies have demonstrated a protective role of …
widely used analgesic drugs. Previous studies have demonstrated a protective role of …
Pioglitazone, a PPARγ agonist, reduces cisplatin-evoked neuropathic pain by protecting against oxidative stress
Painful peripheral neuropathy is a dose-limiting side effect of cisplatin treatment. Using a
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARg synthetic …
murine model of cisplatin-induced hyperalgesia, we determined whether a PPARg synthetic …
PPARs and pain
Chronic pain is a common cause of disability worldwide and remains a global health and
socio‐economic challenge. Current analgesics are either ineffective in a significant …
socio‐economic challenge. Current analgesics are either ineffective in a significant …